Home » News » Currently Reading:

Athenahealth To Acquire Epocrates for $293 Million

January 7, 2013 News 1 Comment

1-7-2013 7-53-53 AM

Athenahealth announced this morning that it has signed a definitive agreement to acquire mobile application and clinical reference data vendor Epocrates for $11.75 per share, representing a 22 percent premium over Friday’s closing share price. The all-cash transaction is valued at $293 million.

Jonathan Bush, president, chairman, and CEO of athenahealth, said of the acquisition, “I have been an admirer of Epocrates since it first emerged and have watched the company grow consistently, one app download at a time, as it has cemented itself into the consciousness of America’s physicians. No other company has been able to replicate the brand awareness, familiarity, and trust that Epocrates has across the clinical mobile user base. We are confident that we can provide Epocrates with the stewardship and resources it needs to grow and develop within health care, and that Epocrates’ capabilities are going to mesh exceptionally well with athenahealth’s cloud-based physician and patient services. Together, we’re excited by the opportunity to redefine the mobile toolset for care givers.”

1-7-2013 8-07-48 AM

Epocrates held its IPO in February 2011. Shares rose quickly from the $13-15 opening range to over $26, but have traded mostly below $10 for the past 16 months. The two-year share price chart above shows Epocrates (blue) and athenahealth (red).

View/Print Text Only View/Print Text Only

HIStalk Featured Sponsors


Currently there is "1 comment" on this Article:

  1. So athena is buying a mobile app with reference material sponsored by drug manufacturers. how does this make their EHR better again? if they had $290 million to spend, why not use that to make the software better?

Subscribe to Updates



Text Ads

Report News and Rumors

No title

Anonymous online form
Rumor line: 801.HIT.NEWS



Founding Sponsors


Platinum Sponsors































































Gold Sponsors















Reader Comments

  • richie: Wonderful topic (I'm biased as I strive to implement systems I'd want, prior to my own long-term care becoming imminent)...
  • richie: Thanks Ed, I'm impressed by your ability to pursue new endeavors....
  • Melissa: I have enjoyed your posts every month, and have followed you through your life changes as well as mine. Thank you for a...
  • Edward Marx: That would make for a good post! Let me think on it and look for me on LinkedIn....
  • Rebecca: Thank you, Ed. I always looked forward to your posts - they were a validation to me that you don't have to have to be a...
  • Lee David Milligan: Rob: thanks for the comment. Agree with your point re: unique expectations and complexity....
  • Shelly: Thank you Ed for taking the time to invest in the industry as you have done - with this blog as a sounding board for CIO...
  • Appreciatve: Thanks,, Ed. This was a very nice piece, and telling of what you cherish most. There is one topic that I am not cert...
  • Rob Price: Excellent information and quite consistent with my experiences since 1999 working with three different software companie...
  • Cosmos: Thank you for the interesting article. FYI - the terms "Severe Sepsis" and "Septicemia" are no longer in common use, ...

Sponsor Quick Links